Application 207056
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | NYLIA 1/35 | ETHINYL ESTRADIOL; NORETHINDRONE | TABLET;ORAL-28 | 0.035MG;1MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 65862-898 | Nylia 1/35 | Norethindrone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-898 | Nylia 1/35 | Norethindrone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-898 | Nylia 1/35 | Norethindrone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-898 | Nylia 1/35 | Norethindrone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-898 | Nylia 1/35 | Norethindrone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-898 | Nylia 1/35 | Norethindrone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-898 | Nylia 1/35 | Norethindrone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |